ArticleTranslational lung cancer research2020

Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?

Jacques De Greve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.